Pneumococcal Disease
Showing NaN - NaN of 5
Pneumococcal Disease Trial in United States (Experimental 20-valent pneumococcal conjugate vaccine (20vPnC), Saline, Influenza
Completed
- Pneumococcal Disease
- Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Mobile, Alabama
- +62 more
Jun 15, 2022
Pneumococcal Disease Trial in United States (20vPnC)
Completed
- Pneumococcal Disease
- 20vPnC
-
Fayetteville, Arkansas
- +41 more
May 24, 2022
Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),
Completed
- Pneumococcal Disease
- +2 more
- 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Anaheim, California
- +28 more
Mar 23, 2022